Don't Buy Albemarle Without Checking Its Fundamentals!

Shares of Industrials sector company Albemarle moved 1.1% today, and are now trading at a price of $231.44. The large-cap stock's daily volume was 175,504 compared to its average volume of 2,324,166. The S&P 500 index returned a 0.0% performance.

Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. The company is based in Charlotte and has 7,400 full time employees. Its market capitalization is $27,155,656,704. Albemarle currently offers its equity investors a dividend that yields 0.7% per year.

25 analysts are following Albemarle and have set target prices ranging from $155.0 to $360.0 per share. On average, they have given the company a rating of buy. At today's prices, ALB is trading -12.18% away from its average analyst target price of $263.54 per share.

Over the last year, ALB's share price has increased by 6.4%, which represents a difference of -9.0% when compared to the S&P 500. The stock's 52 week high is $334.55 per share whereas its 52 week low is $171.82. Albemarle has averaged free cash flows of $-36798000.0 over the last 4 years, but they have been increasing at a rate of 55.7%. Nonetheless, more cautious investors will probably avoid this stock until the business becomes firmly cash positive.

Date Reported Cash Flow from Operations ($ k) Capital expenditures ($ k) Free Cashflow ($ k) YoY Growth (%)
2022-12-31 1,907,849 -1,261,646 646,203 206.04
2021-12-31 344,257 -953,667 -609,410 -1081.87
2020-12-31 798,914 -850,477 -51,563 61.06
2019-12-31 719,374 -851,796 -132,422 n/a
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.